Product How it works Pricing Blog FAQ About Contact
Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) financial statements

The consolidated income statement, balance sheet and cash flow statement of Johnson & Johnson for its last 10 fiscal years, as filed with the regulator, in millions of US dollars. At the end of fiscal 2025 it had $199,210m in total assets and $81,544m in equity.

Income statement

Item2025202420232022202120202019201820172016
Revenue$94,193m$88,821m$85,159m$79,990m$78,740m$82,584m$82,059m$81,581m$76,450m$71,890m
Cost of sales$30,256m$27,471m$26,553m$24,596m$23,402m$28,427m$27,556m$27,091m$25,439m$21,789m
Gross profit$63,937m$61,350m$58,606m$55,394m$55,338m$54,157m$54,503m$54,490m$51,011m$50,101m
Operating profit$33,552m$17,442m$15,834m$19,635m$19,361m$16,698m$17,646m$19,004m$18,607m$20,529m
Finance costs$971.0m$755.0m$772.0m$276.0m$183.0m$201.0m$318.0m$1,005m$934.0m$726.0m
Profit before tax$32,581m$16,687m$15,062m$19,359m$19,178m$16,497m$17,328m$17,999m$17,673m$19,803m
Income tax$5,777m$2,621m$1,736m$2,989m$1,377m$1,783m$2,209m$2,702m$16,373m$3,263m
Net profit$26,804m$14,066m$35,153m$17,941m$20,878m$14,714m$15,119m$15,297m$1,300m$16,540m
Earnings per share$11.13$5.84$13.88$6.83$7.93$5.59$5.72$5.70$0.48$6.04
Diluted earnings per share$11.03$5.79$13.72$6.73$7.81$5.51$5.63$5.61$0.47$5.93
Depreciation and amortisation$7,503m$7,339m$7,486m$6,970m$7,390m$7,231m$7,009m$6,929m$5,642m$3,754m

Balance sheet

Item2025202420232022202120202019201820172016
Total assets$199,210m$180,104m$167,558m$187,378m$182,018m$174,894m$157,728m$152,954m$157,303m$141,208m
Current assets$55,624m$55,893m$53,495m$55,294m$60,979m$51,237m$45,274m$46,033m$43,088m$65,032m
Inventories$14,191m$12,444m$11,181m$10,268m$10,387m$9,344m$9,020m$8,599m$8,765m$8,144m
Property, plant and equipment$23,169m$20,518m$19,898m$17,982m$18,962m$18,766m$17,658m$17,035m$17,005m$15,912m
Goodwill$48,772m$44,200m$36,558m$36,047m$25,436m$36,393m$33,639m$30,453m$31,906m$22,805m
Cash$19,709m$24,105m$21,859m$12,889m$14,487m$13,985m$17,305m$18,107m$17,824m$18,972m
Total liabilities$117,666m$108,614m$98,784m$110,574m$107,995m$111,616m$98,257m$93,202m$97,143m$70,790m
Current liabilities$54,126m$50,321m$46,282m$55,802m$45,226m$42,493m$35,964m$31,230m$30,537m$26,287m
Equity$81,544m$71,490m$68,774m$76,804m$74,023m$63,278m$59,471m$59,752m$60,160m$70,418m
Equity including minorities$81,544m$71,490m$68,774m$76,804m$74,023m$63,278m$59,471m$59,752m$60,160m$70,418m

Cash flow statement

Item2025202420232022202120202019201820172016
Operating cash flow$24,530m$24,266m$22,791m$21,194m$23,410m$23,536m$23,416m$22,201m$21,056m$18,767m
Investing cash flow−$23,588m−$18,599m$878.0m−$12,371m−$8,683m−$20,825m−$6,194m−$3,167m−$14,868m−$4,761m
Financing cash flow−$5,539m−$3,132m−$15,825m−$8,871m−$14,047m−$6,120m−$18,015m−$18,510m−$7,673m−$8,551m
Capital expenditure−$4,832m−$4,424m−$4,543m−$4,009m−$3,652m−$3,347m−$3,498m−$3,670m−$3,279m−$3,226m

Where each figure comes from

From the annual report (Form 10-K) that Johnson & Johnson files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Johnson & Johnson page.

Dividend per share of Johnson & Johnson by fiscal year, with the filing behind every figure: Johnson & Johnson dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.